T1	Participants 292 337	patients with chronic immune thrombocytopenia
T2	Participants 437 582	adults with previously treated immune thrombocytopenia of more than 6 months' duration who had baseline platelet counts lower than 30,000 per Î¼L.
T3	Participants 1508 1520	197 patients